Vericel (VCEL) Change in Inventory (2014 - 2026)
Vericel (VCEL) reported Change in Inventory of $964000.0 for Q1 2026, up 461.05% on a YoY basis from $171821.1 in Q1 2025, and up 115.18% sequentially from $448000.0 in Q4 2025.
Vericel (VCEL) Change in Inventory (2014 - 2026) Analysis & Trends
Vericel (VCEL) has 13 years of Change in Inventory data on file, last reported at $964000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 461.05% year-over-year to $964000.0; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 30.66% YoY), and the FY2025 full-year result was $1.2 million, down 71.3% from the prior year.
- Change in Inventory advanced to $964000.0 in Q1 2026, from $448000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.6 million in Q4 2024 to a low of -$1.5 million in Q2 2023.
- A 5-year average of $363882.4 and a median of $470000.0 in 2024 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 700.0% in 2022, while the deepest fall reached 330.75% in 2022.
- Tracing VCEL's Change in Inventory over 5 years: stood at -$743000.0 in 2022, then jumped by 162.72% to $466000.0 in 2023, then jumped by 247.0% to $1.6 million in 2024, then tumbled by 72.29% to $448000.0 in 2025, then soared by 115.18% to $964000.0 in 2026.
- Business Quant data shows VCEL's Change in Inventory at $964000.0 in Q1 2026, $448000.0 in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 964,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 964,000.00 |
| Mar 31, 2026 | 964,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | -275,000.00 |
| Jun 30, 2025 | -275,000.00 |
| Mar 31, 2025 | -267,000.00 |
| Mar 31, 2025 | -267,000.00 |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 869,000.00 |
| Sep 30, 2024 | 869,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 470,000.00 |
| Mar 31, 2024 | 470,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Dec 31, 2023 | 466,000.00 |